Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Go back to Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology| (NASDAQ: DFTX) | Delayed: 38.81 +0.13 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.68 | 52 Week High | $ | |||
| Open | $38.67 | 52 Week Low | $ | |||
| Day High | $39.04 | P/E | N/A | |||
| Day Low | $38.10 | EPS | $ | |||
| Volume | 3,215,195 | |||||
